10% OFF Crypto | 3rd Party Tested | FREE Worldwide Shipping $400+ ($750+ for USA)
Menu
Cart
cerebrolysin 30 mg lyophilized peptide vial
lyophilized peptide vial box (white cap)

Cerebrolysin (cerebroprotein hydrolysate) 30 mg – 10 Vial Box

$160.0

Cost per vial $: 16

Buy cerebrolysin (cerebroprotein hydrolysate) 30 mg (one 10-vial box). All orders are shipped wholesale in unbranded packaging. Worldwide 7 – 14 day shipping to the USA, UK, AUS & NZ.

Bulk discounts
Quantity Bulk Discount Price
210%$144.0
3-515%$136.0
6-1020%$128.0
SKU: CER Category:

Description

Cerebrolysin is a unique peptide blend researched for its potential to support brain health and cognitive function. Researchers have studied cerebrolysin for conditions such as Alzheimer’s disease, stroke recovery, traumatic brain injury (TBI), cognitive decline, and neurodegenerative disorders, focusing on its potential to support brain repair, memory, and overall cognitive function.

Our form of cerebrolysin is called cerebroprotein hydrolysate. It can be reconstituted with bacteriostatic water and used in the same way as regular cerebrolysin.

Minimum order quantity: one box (10 vials x 30 mg).

Note: Product images show branded labels for illustration purposes only. All peptides are shipped in wholesale, unbranded packaging. You can see an actual example photo of the peptide vials and container above.

 

Additional information

Purity

≥99.0%
Cost per vial $

16
  1. Plosker, Greg L., and Serge Gauthier. "Cerebrolysin: a review of its use in dementia." Drugs & aging 26 (2009): 893-915.
  2. Ziganshina, Liliya Eugenevna, et al. "Cerebrolysin for acute ischaemic stroke." Cochrane Database of Systematic Reviews 10 (2023).
  3. Ladurner, G., P. Kalvach, and H. Moessler. "Neuroprotective treatment with cerebrolysin in patients with acute stroke: a randomised controlled trial." Journal of neural transmission 112 (2005): 415-428.
  4. Bornstein, Natan M., et al. "Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials." Neurological Sciences 39 (2018): 629-640.
  5. Cui, Shuhui, et al. "Cerebrolysin for vascular dementia." Cochrane Database of Systematic Reviews 11 (2019).
  6. Zhang, Chunling, et al. "Cerebrolysin enhances neurogenesis in the ischemic brain and improves functional outcome after stroke." Journal of neuroscience research 88.15 (2010): 3275-3281.

Related products